Zhou H - Search Results

1

Adult Primary Pineal Alveolar Rhabdomyosarcoma with FOXO1 Gene Rearrangement and OLIG2 Expression: A Rare Case Report and Literature Review.

Xie L, Wang W, Zhou H, Han Z, Xu J, Xu Z, Xiang J. Xie L, et al. Among authors: zhou h. Int J Surg Pathol. 2022 Oct;30(7):769-775. doi: 10.1177/10668969221080076. Epub 2022 Feb 21. Int J Surg Pathol. 2022. PMID: 35188829 Review.

2

Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.

Jin E, Wang W, Fang M, Wang W, Xie R, Zhou H, Ye J, Xu R, Ma S. Jin E, et al. Among authors: zhou h. Oncol Lett. 2019 Jan;17(1):502-507. doi: 10.3892/ol.2018.9537. Epub 2018 Oct 2. Oncol Lett. 2019. PMID: 30655793 Free PMC article.

3

[Expression of human epidermal growth factor receptor 2 in mucinous carcinoma of breast].

Wang W, Xiang J, Zhou H, Xu R. Wang W, et al. Among authors: zhou h. Zhonghua Bing Li Xue Za Zhi. 2015 Apr;44(4):278-9. Zhonghua Bing Li Xue Za Zhi. 2015. PMID: 25975914 Chinese. No abstract available.

4

[Expression of BRAF and RAS mutations in different histologic subtypes of papillary thyroid carcinoma].

Wang W, Li X, Xiang J, Zhao P, Zhou H, Xu R. Wang W, et al. Among authors: zhou h. Zhonghua Bing Li Xue Za Zhi. 2015 May;44(5):331-3. Zhonghua Bing Li Xue Za Zhi. 2015. PMID: 26178216 Chinese. No abstract available.

5

Anti-PD-1 treatment-induced immediate central diabetes insipidus: a case report.

Yu M, Liu L, Shi P, Zhou H, Qian S, Chen K. Yu M, et al. Among authors: zhou h. Immunotherapy. 2021 Oct;13(15):1255-1260. doi: 10.2217/imt-2020-0334. Epub 2021 Aug 23. Immunotherapy. 2021. PMID: 34424037

6

Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia.

Guo H, Lin J, Wen XM, Yang J, Qian W, Deng ZQ, Ma JC, Tang CY, An C, Liu Q, Zhou H, Qian J. Guo H, et al. Among authors: zhou h. Int J Clin Exp Pathol. 2014 Jul 15;7(8):4695-703. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25197341 Free PMC article.

7

Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2'-5'-oligoadenylate synthetase 2 axis in acute myeloid leukemia.

Zhou H, Jia X, Yang F, Shi P. Zhou H, et al. Bioengineered. 2021 Dec;12(1):6403-6417. doi: 10.1080/21655979.2021.1971508. Bioengineered. 2021. PMID: 34516354 Free PMC article.

8

miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6).

Zhou H, Jia X, Yang F, Shi P. Zhou H, et al. Bioengineered. 2021 Dec;12(1):4508-4519. doi: 10.1080/21655979.2021.1956400. Bioengineered. 2021. PMID: 34308752 Free PMC article.

9

Small-Molecule Inhibitors Targeting eIF4A in Leukemia.

Jia X, Zhou H. Jia X, et al. Among authors: zhou h. Curr Protein Pept Sci. 2021;22(7):559-566. doi: 10.2174/1389203722666210526155808. Curr Protein Pept Sci. 2021. PMID: 34042032 Review.

10

Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis.

Xu XH, Gan YC, Xu GB, Chen T, Zhou H, Tang JF, Gu Y, Xu F, Xie YY, Zhao XY, Xu RZ. Xu XH, et al. Among authors: zhou h. J Zhejiang Univ Sci B. 2012 Nov;13(11):867-74. doi: 10.1631/jzus.B1200021. J Zhejiang Univ Sci B. 2012. PMID: 23125079 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,222 results

Search Page

Filters